Even lower doses of Ethambutol can Induce Optic Neuropathy, suggests a study published in the Cureus.The present study aims ...
2 天
Clinical Trials Arena on MSNImmunoGenesis doses first subject in Phase I/II trial of hypoxia reversal agentImmunoGenesis has initiated the first subject dosing in a multicentre Phase I/II trial of IMGS-101 (evofosfamide), the ...
3 天
Health on MSNZepbound Is Now Available in Additional Doses at Lower CostsFact checked by Nick Blackmer Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, ...
Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.
2 天
The Daily Monitor on MSNUganda receives 2 million malaria vaccine dosesDr Aceng noted that Uganda is the 19th country in the world to introduce the malaria vaccine and is undertaking the largest ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...
Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, ...
KAMPALA, UGANDA | THE INDEPENDENT | The Ministry of Health has flagged off the distribution of 2.278 million doses of malaria ...
Revelation Biosciences (REVB) announced dosing of the first patient in the PRIME, or PReconditioning IMmunostimulatory Evaluation, Phase 1b ...
12 天
GlobalData on MSNHealx doses first subject in Phase II neurofibromatosis type 1 therapy trialHealx has dosed the first subject in the open-label Phase II INSPIRE-NF1 trial to assess the efficacy and safety of HLX-1502 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果